(BSNS WIRE) La Jolla Diagnostics Inc. Announces Additions to Board
La Jolla Diagnostics Inc. Announces Additions to Board
Business Editors
LA JOLLA, Calif.--(BW HealthWire)--Oct. 13, 1998--La Jolla
Diagnostics Inc. (OTC BB: LAJD), announced today the addition of two
new board members.
Joining the Board of Directors will be G. Bruce Whitfield, J.D.,
and Stephen C. Roberts, M.D., both previously of ATS Inc.
Whitfield was previously a founder and partner of the law firm of
DeBenon and Whitfield, specializing in the practice of business
transactional law and litigation. Whitfield has participated in
the formation and development of several successful ventures including
United Staffing Solutions and Bixel Financial, where in each case he
continues presently as a board member.
Roberts was formerly a principal of Maven Securities Inc., an
investment banking firm, and was a founder and partner in Talon
Associates, a consulting firm specializing in market evaluation and
planning for medical device companies. Roberts received his
medical degree from the University of Minnesota Medical School and
completed his internship at Bergen Pines County Hospital in New
Jersey, an affiliate of the University of Medicine and Dentistry of
New Jersey. He currently serves on the boards of Sojourn Adult Day
Care Centers and Maven Holdings.
"We are very pleased to add Mr. Whitfield and Dr. Roberts to our
board", said Don Brucker, chief executive officer of La Jolla
Diagnostics. "Mr. Whitfield, in addition to his credentials as a well
known business lawyer, brings with him exceptional experience in
having guided several start-up ventures to success. Dr. Roberts, in
addition to his medical background, brings with him crucial experience
in finance. I believe we now have a unique combination of skills and
experience that augers well for our success. We have depth in
management and on the board that is seldom found in a development
stage company."
"This small company has what is, in my opinion, an outstanding
diagnostic for TB, as well as a migraine treatment of great promise,"
said Roberts. "La Jolla Diagnostics has a tremendous opportunity
to do good for the world through these products. I am enthusiastically
looking forward to assisting in the growth of this enterprise."
Whitfield said, "We now have all of the essential ingredients for
success. My goal is to assist wherever possible with the execution of
our plan to make this a substantial company."
La Jolla Diagnostics is an emerging company, engaged in the
development and marketing of diagnostic tests, health care products
and nutraceuticals. The healthcare and nutraceuticals products are
formulated using a patented clustered water technology. U.S. Patent
5711950
La Jolla Diagnostics Inc., 7777 Fay Ave., Suite 160, La Jolla,
Calif., 92037 Phone 800/454-6790 Fax 619/454-7851 lajd.com,
e-mail: lajd96@aol.com.
--30--jm/sd* el/sd
CONTACT: La Jolla Diagnostics Inc.
Don Brucker, 800/454-6790
lajd.com
lajd96@aol.com
KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICALS MEDICINE
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
*** end of story ***
|
